[1] Kim BK,Kim HS,Park JY,et al. Prospective validation of ELF test in comparison with Fibroscan and predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One,2012,7:e41964.
[2] Chan HL,Wong GL,Choi PC,et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transientelastography(Fibroscan)for liver fibrosis in chronic hepatitis B. J Viral Hepatol,2009,16:36-44.
[3] Pinzani M,Vizzutti F,Arena U,et al. Technology insight:noninvasive assessment of liver fibrosis by biochemical scores and elastography.Nat Clin Pract Gastroenterol Hapatol,2008,5:95-106.
[4] Marcelin P,Ziol M,Bedossa P,et al.Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.Liver Int,2009,29:242-247.
[5] Chon YE,Choi EH,Song KJ,et al.Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B:a meta-analysis. PloS One,2012,7:e44930.
[6] Guidelines for the Prevention, Care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization,2015.
[7] Enomoto M,Mori M,Ogawa T,et al.Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B:Regression of liver stiffness during entecavir therapy.Hepatol Res,2010,40:853-861.
[8] Chang TT,Liaw YF,Wu SS,et al.Long-sterm entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.Hepatology,2010,52:886-893.
[9] 郭凤彩,濮翔科,龚箐,等.瞬时弹性扫描仪在评价恩替卡韦治疗乙型肝炎代偿期肝硬化患者中的应用.中华传染病杂志,2012,30:555-557.
[10] Ziol M,Handra-Luca A,Kettaneh A,et al.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.Hepatology,2005,41(1):48-54.
[11] 汪月娥,张天嵩,范清琪,等.瞬时弹性成像技术对慢性丙型肝炎肝纤维化和肝硬化患者诊断价值的Meta分析.中华传染病杂志,2014,32:616-621.
[12] Guidelines for the Screening.Care and treatment of persons with hepatitis C infection. Geneva: World Health Organization,2014.
[13] Yoneda M,Fujita K,et al.Transient elastography in patients with non-alcoholic fatty liver disease(NAFLD).Gut,2007,56:1330-1331.
[14] Wong VW, Vergniol J,Wong GL,et al.Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology,2010,51:454-462.
[15] 欧晓娟,王晓明,吴晓宁,等.FibroTouch与FibroScan在慢性乙型肝炎患者纤维化评估中的比较.中华肝脏病杂志,2015,23:103-106.
[16] 郑剑,杨丽新,吴涛,等.瞬时弹性成像与实时组织弹性成像评估肝纤维化的比较.中国肝脏病杂志,2014,22: 731-734.
[17] Verveer C,Zondervan PE,ten Kate FJ,ea al.Evaluation of trasient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int,2012,32:622-628.
[18] Oliveri F,Coco B,Ciccorossi P,et al.Liver Stiffiness in the hepatitis B virus Carrier:a non-invasive marker of liver disease influnced by the patterm of transaminases.World J Gastroenterol,2008,14:6154-6162.
[19] Chan HL,Wang GL,Choi PC,et al.Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography(Fibroscan)for liver fibrosis in chronic hepatitis B.J Viral Hepat,2009,16:36-44.
[20] Gaia S,Carenzi S,Barilli AL,et al.Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol,2011,54:64-71.
[21] Roulot D,Costes JL,Buyck JF,et al.Transient elastography as a screening tool for liver fibrosis cirrhosis in a community-based population aged over 45 years.Gut,2011,60:927-984.
[22] 罗建文,邵金华,白净,等.瞬时弹性成像技术用于肝纤维化的无创评价.中华肝脏病杂志,2006,14:395-397. |
